Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Joining us is the company Sanofi and Regeneron to talk to us more about COPD also known as Chronic Obstructive Pulmonary ...

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

Study objectives: To identify the predictors of medication adherence in patients with COPD and contrast the health beliefs, experiences, and behaviors of COPD patients self-reporting good ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an ...

Two pharmacists with experience in respiratory medicine and two pharmacy practice ... A nutrition guide for patients with COPD was included as an ethically acceptable incentive to encourage ...

The drug, Dupixent, showed a reduction of at least 30% in the annualized rate of moderate or severe COPD in a pair of Phase 3 studies. The drug was previously approved for the treatment of other ...

Opens in a new tab or window “Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data ...